DCBLD2 p.Val693Ala
c.2078T>C · VCV3838482
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0616 | likely benign |
|---|---|---|
| REVEL | 0.017 | moderately benign-leaning |
| SaProt | LLR -5.45 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 0.55 | GERP -4.2 |
| Regional constraint | o/e 0.89 | unconstrained · MANE · 23 kb · p 0.0054 · regional, not allelic |
| Overall | ||
| CADD | 5.669 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| East Asiangrpmax | 0.00668% | 14,959 |
| European (non-Finnish) | 0.0028% | 35,754 |
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,484 |
| Finnishnot grpmax-eligible | 0.00156% | 64,022 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- DCBLD2
- Protein
- p.Val693Ala
- Coding
- c.2078T>C
- MANE Select
- NM_080927
- Type
- single nucleotide variant
- Location
- chr3:98799622 (GRCh38)
- Gene constraint
- LOEUF 0.808 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 68.13
- Residue 693
- the 'disordered' region
Similar variants
- DCBLD2 p.Lys391= Benign ★★ same type
- DCBLD2 p.Ala182Thr Uncertain significance ★ ⚠ same type
- DCBLD2 p.Ala24Ser Uncertain significance ★ ⚠ same type
- DCBLD2 p.Ala304Glu Uncertain significance ★ ⚠ same type
- DCBLD2 p.Ala304Thr Uncertain significance ★ ⚠ same type
- DCBLD2 p.Ala304Val Uncertain significance ★ ⚠ same type
- DCBLD2 p.Ala341Thr Uncertain significance ★ ⚠ same type
- DCBLD2 p.Ala482Asp Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dcbld2-p-val693ala (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown